unknown
Stage
1
Investors
About
ViaNautis develops 'bionic nanoparticles' (branded Polynaut) and offers pharma-facing services including live-cell imaging to support drug discovery and preclinical testing.
Explore ViaNautis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.